Esperion Therapeutics, Inc. (ESPR) — Stock Score Summary

Esperion Therapeutics, Inc. (ESPR) has a MoatMap StockRank of 35/100 based on Quality (45/100), Value (36/100), and Momentum (42/100) factor scores. The current signal is HOLD.

Esperion Therapeutics, Inc. is a pharmaceutical company focused on developing and commercializing oral therapies for patients with elevated LDL-cholesterol (LDL-C) and other cardiovascular risk factors. The company's approved products, NEXLETOL® and NEXLIZET®, offer new treatment options for individuals unable to reach cholesterol goals with statins or those who are statin intolerant. Esperion holds a niche position in the cardiovascular drug market, addressing unmet needs in dyslipidemia management.

Key Financial Metrics

Price$3.13
Market Cap$806M
P/E (Forward)10.68
Price/Book-2.53
Return on Invested Capital38.6%
Gross Margin57.8%
Operating Margin-8.2%
Revenue Growth23.2%
Free Cash Flow$-50M

Esperion Therapeutics, Inc. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Esperion Therapeutics, Inc.’s (ESPR) StockRank?
MoatMap’s StockRank for Esperion Therapeutics, Inc. (ESPR) is 35/100, with a Hold signal. It is a composite of Quality (45), Value (36), and Momentum (42) factor ranks across MoatMap’s 19,000+ stock universe.
Does Esperion Therapeutics, Inc. have an economic moat?
Esperion Therapeutics, Inc. (ESPR) has a Quality factor score of 45/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Esperion Therapeutics, Inc. a buy, hold, or sell?
MoatMap’s current signal for Esperion Therapeutics, Inc. (ESPR) is Hold, based on a StockRank of 35/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Esperion Therapeutics, Inc. in?
Esperion Therapeutics, Inc. (ESPR) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (United States).
Browse all ranked stocksESPR deep dive reportAI ChampionsHow we score stocksSense-check another stock